Wordt geladen...
The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells
In human cancer cells that harbor mutant KRAS and WT p53 (p53), KRAS contributes to the maintenance of low p53 levels. Moreover, KRAS depletion stabilizes and reactivates p53 and thereby inhibits malignant transformation. However, the mechanism by which KRAS regulates p53 is largely unknown. Recentl...
Bewaard in:
| Gepubliceerd in: | J Biol Chem |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Biochemistry and Molecular Biology
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7062149/ https://ncbi.nlm.nih.gov/pubmed/32001619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.RA119.011930 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|